Pharmaceutical firms are keen on reclassification of drugs

As a number of prescription drugs, including an anti-ulcerant Zantac and a contraceptive Norlevo, are likely be reclassified into over-the-counter (OTC) drugs, some pharmaceutical firms are said to seek to expand pharmacy sales of more OTC drugs.

An official at a major pharmaceutical company said most of the 48 liberalized medicines are not popular, and probably wouldn’t see much sales at su...